Dr. Ali Sakhdari is an Assistant Professor of Hematopathology with a multifaceted research portfolio spanning various aspects of hematopathology, immunology, and oncology. He received his medical degree from Mashhad University of Medical Sciences and completed his pathology residency at the University of Massachusetts and his hematopathology fellowship at MD Anderson Cancer Center. With a solid foundation in both clinical practice and research, his interests encompass the molecular and cellular mechanisms underlying hematologic malignancies, particularly lymphomas and leukemias. His research efforts are characterized by a multidisciplinary approach, integrating advanced molecular techniques, immunohistochemistry, and genomic profiling to elucidate the genetic, epigenetic, and immunologic factors contributing to disease pathogenesis. A notable focus of his work involves understanding the immune microenvironment of hematologic tumors, investigating interactions between tumor cells and the host immune system, and exploring novel immunotherapeutic strategies. He is dedicated to training the next generation of pathologists and hematopathologists, fostering a collaborative learning environment, and promoting evidence-based medicine. As an active member of various professional societies and committees, he contributes to advancing diagnostic and therapeutic standards in hematopathology, participating in peer review activities, editorial roles, and organizing scientific conferences.
Short Biography
Dr. Ali Sakhdari is an Assistant Professor of Hematopathology with a multifaceted research portfolio spanning various aspects of hematopathology, immunology, and oncology. He received his medical degree from Mashhad University of Medical Sciences and completed his pathology residency at the University of Massachusetts and his hematopathology fellowship at MD Anderson Cancer Center. With a solid foundation in both clinical practice and research, his interests encompass the molecular and cellular mechanisms underlying hematologic malignancies, particularly lymphomas and leukemias. His research efforts are characterized by a multidisciplinary approach, integrating advanced molecular techniques, immunohistochemistry, and genomic profiling to elucidate the genetic, epigenetic, and immunologic factors contributing to disease pathogenesis. A notable focus of his work involves understanding the immune microenvironment of hematologic tumors, investigating interactions between tumor cells and the host immune system, and exploring novel immunotherapeutic strategies. He is dedicated to training the next generation of pathologists and hematopathologists, fostering a collaborative learning environment, and promoting evidence-based medicine. As an active member of various professional societies and committees, he contributes to advancing diagnostic and therapeutic standards in hematopathology, participating in peer review activities, editorial roles, and organizing scientific conferences.
Advance your academic career, collaborate globally, and expand your network—
join now
!
Well done!
